Variant report
Variant | nsv823841 |
---|---|
Chromosome Location | chr6:132549331-132549920 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000118523 | chromatin interactions |
ENSG00000227220 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537247992 | chr6:132549336-132549337 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs374086367 | chr6:132549355-132549356 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs192529825 | chr6:132549374-132549375 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs184389049 | chr6:132549375-132549376 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs542950289 | chr6:132549400-132549401 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs367668560 | chr6:132549407-132549408 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs73781466 | chr6:132549408-132549409 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs538875104 | chr6:132549427-132549428 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs79919581 | chr6:132549450-132549451 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs189624177 | chr6:132549497-132549498 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs1321259 | chr6:132549499-132549500 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs193095637 | chr6:132549501-132549502 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs564036227 | chr6:132549506-132549507 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs12664012 | chr6:132549516-132549517 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs73781467 | chr6:132549519-132549520 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs537807453 | chr6:132549525-132549526 | Weak transcription Flanking Active TSS Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs554626742 | chr6:132549638-132549639 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs78837637 | chr6:132549641-132549642 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs540555833 | chr6:132549652-132549653 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs549344137 | chr6:132549674-132549675 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs142955479 | chr6:132549685-132549686 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs112972225 | chr6:132549686-132549687 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs551803168 | chr6:132549704-132549705 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs1321260 | chr6:132549734-132549735 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs146640597 | chr6:132549754-132549755 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs537616209 | chr6:132549780-132549781 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs189020439 | chr6:132549782-132549783 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs531556316 | chr6:132549787-132549788 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs567549438 | chr6:132549790-132549791 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs140773790 | chr6:132549811-132549812 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs144620329 | chr6:132549822-132549823 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs75243218 | chr6:132549831-132549832 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs79393950 | chr6:132549881-132549882 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs577681281 | chr6:132549901-132549902 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:132548000-132550800 | Enhancers | Osteobl | bone |
2 | chr6:132548400-132549400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr6:132548800-132549400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:132548800-132549400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr6:132548800-132549400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr6:132548800-132550800 | Enhancers | NH-A | brain |
7 | chr6:132549200-132549600 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr6:132549200-132550800 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr6:132549200-132551000 | Enhancers | HSMM | muscle |
10 | chr6:132549200-132551000 | Enhancers | HSMMtube | muscle |
11 | chr6:132549200-132553000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr6:132549400-132551600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr6:132549400-132551800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr6:132549400-132551800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr6:132549400-132556000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
16 | chr6:132549600-132551000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |